Dogwood Therapeutics Inc.
DWTX | NASDAQ
$1.63
-$0.06 (-3.55%)
At close: Sep 21, 2026, 3:59 PM ET
$1.73
+$0.10 (+5.91%)
Pre-market:
Sep 22, 2026, 9:15 AM ET
Market Data
Market Cap $53.81M
Enterprise Value $45.33M
Beta 1.83
Average Volume 78.78K
Shares Outstanding (Diluted) 34.13M
Shares Change YoY 2267.58%
Institutional Ownership 10.79%
Exchange NASDAQ
ISIN US92829J2033
Price Performance
Price Change 1M -35.1%
Price Change 3M 5.2%
Price Change 6M -29.4%
Price Change YTD -61.6%
Price Change 1Y -68.5%
Price Change 3Y -93.1%
Price Change 5Y -98.8%
1M CAGR (ann.) -11.6%
1Y CAGR (ann.) -66.7%
5Y CAGR (ann.) -59.4%
All-Time CAGR -61.9%
Valuation
PE Ratio -0.18
Forward PE N/A
PEG Ratio -0.00
Forward PEG 0.01
PS Ratio N/A
Forward PS 2.90
PB Ratio 0.80
P/FCF Ratio -3.63
P/Adj. FCF Ratio -3.58
P/OCF Ratio -3.70
EV/Sales N/A
EV/EBIT -1.54
EV/EBITDA -1.55
EV/FCF -3.00
Earnings Yield -549.1%
FCF Yield -27.6%
Adj. FCF Yield -27.9%
Financial Health
Net Cash $9.55M
Total Debt $127.21K
Cash & Short-Term Investments $9.61M
Total Assets $80.5M
Current Ratio 3.89
Quick Ratio 3.89
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.01
OCF / Debt -118.77
Interest Coverage 0.00
Altman Z-Score -0.59
Piotroski F-Score 1
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -1.4%
Returns
Return on Assets -44.8%
Return on Equity -47.9%
Return on Invested Capital -35.6%
Return on Capital Employed -38.1%
Return on Tangible Assets -322.2%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y -13.9%
EPS CAGR 5Y 39.2%
EPS CAGR 10Y N/A
FCF CAGR 3Y -46.8%
FCF CAGR 5Y -8.9%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 1
EPS Growth Next 3Y 32.5%
Revenue Growth Next 3Y N/A
Earnings Date Nov 4, 2026
EPS Estimate (next Q) -$0.15
EPS Growth Est (next Q) -98.2%
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $12
Price Target Upside 636.2%
Cash Flow
Operating Cash Flow $-15.11M
Free Cash Flow $-15.11M
Adj. Free Cash Flow $-15.31M
FCF Per Share -$0.44
OCF Per Share -$0.44
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $-16.69K
Operating Income $-29.56M
EBITDA $-29.3M
Net Income $-36.04M
EPS (Diluted) -$8.95
Revenue / Employee N/A
Profit / Employee $-4.51M
Employees 8
Add to Watchlist
Select watchlists to add or remove DWTX